How Drug and Health Screening Is Changing for Employers

Drug screening remains a significant focus for employers across industries. According to the 2026 Quest Diagnostics Drug Testing Index™, workforce drug positivity rates have remained above 4% for more than a decade, underscoring the ongoing importance of workplace screening programs and risk mitigation strategies.

But drug and health screening programs have evolved significantly over the last decade. Today, employers face a more complex landscape shaped by changing regulations, workforce expectations, emerging substances, and the need to balance safety with hiring efficiency.

Going Beyond Regulatory Mandates

While regulatory mandates remain a major driver for drug and health screening in industries like transportation, manufacturing, and healthcare, they're far from the only reason employers implement screening programs.

Approximately 40% to 60% of U.S. employers conduct drug testing for non-regulated (non-DOT) roles, with overall broad workplace adoption sitting near 50%–60%.

Many organizations use drug screening as part of a broader risk management strategy to:

• Promote workplace safety
• Support drug-free workplace initiatives
• Meet customer or contract requirements
• Reduce absenteeism and productivity disruptions
• Protect company reputation
• Support employee wellness programs

Exploring Today’s Drug Screening Options

Traditional laboratory-based urine testing remains the most common form of drug screening, especially for regulated industries like transportation. Candidates visit a collection site, provide a specimen, and the sample is sent to a laboratory for analysis.

However, employers now have access to a broader range of testing options.

• Rapid testing solutions can provide negative results almost immediately, helping employers make faster onboarding decisions.
• Oral fluid testing is also growing in popularity, particularly in non-regulated industries where convenience and speed are priorities.

These tests can often be administered onsite without requiring candidates to visit a collection facility.

Beyond drug screening, many organizations are expanding their programs to include occupational health services such as:

• Physical examinations
• Respirator fit testing
• Lift testing
• Vision and hearing screenings
• Vaccination verification
• Immunity titers for healthcare workers

As hiring requirements become more specialized, employers are increasingly looking for screening programs that align with the specific needs of individual roles and industries.

Trends Reshaping Drug Screening Programs

Regulatory changes, advances in drug testing technology, labor market pressures, and emerging public health concerns are forcing employers to reconsider how drug screening programs are structured. As a result, the way employers approach drug screening today looks very different than it did five years ago. Several trends are driving this transformation and are expected to continue influencing employer screening strategies in the years ahead.

Marijuana Regulations Continue to Evolve

As of 2026, marijuana is legal for recreational use in 24 states and Washington D.C. As legalization continues to expand, employers must balance changing state laws with workplace safety and compliance obligations.

In some jurisdictions, employers face restrictions on using positive marijuana test results as the sole basis for denying employment, particularly for non-safety-sensitive positions. Many organizations are now adopting marijuana-excluded testing panels for certain roles while maintaining stricter requirements for safety-sensitive positions.

Rapid Testing is Accelerating Hiring

Rapid testing technologies have gained traction because they can deliver negative results within minutes while routing only non-negative results for additional laboratory analysis. This allows organizations to move qualified candidates through the hiring process more quickly without sacrificing accuracy.

Drug Testing Panels Are Under Review

Another emerging trend is the review of longstanding drug testing panel configurations. Some drug panels still include analytes that have produced few or no positive results for years (e.g. Propoxyphene and Methaqualone have nationwide negative percentages at 0% for the last 5-15 years). This has prompted many drug testing laboratories to phase out these analytes for newer products. Now organizations are evaluating whether their screening programs reflect today’s workforce testing options, including rapid testing and oral fluid testing.

During a recent drug testing webinar, Asurint’s General Counsel, Vince Pascarella, covered the differences in positivity rates between a standard 5-panel and expanded panel.

Employers Are Paying Attention to Fentanyl

Organizations are also paying closer attention to substances such as fentanyl due to growing public health concerns. While fentanyl testing hasn't yet become a standard component of all screening panels, many employers and regulators are monitoring trends closely and evaluating whether testing protocols should evolve to address emerging risks.

Streamlining Compliance Documentation

Employers are increasingly using AI-powered tools to automate drug testing documentation, compliance tracking, and regulatory reporting. These solutions can reduce administrative workload while improving audit readiness and record management.

Common Misconceptions About Drug Screening

Despite how common drug screening programs have become, misconceptions still exist:

• Myth #1: One of the most common myths is that a positive test automatically disqualifies a candidate. However, many non-negative results undergo review by a Medical Review Officer (MRO), who evaluates whether legally prescribed medications may explain the findings. A legitimate prescription can often result in a final negative determination.
  
  In the same drug testing webinar mentioned earlier, Vince also shared what an MRO can and can’t do.

• Myth #2: Another misconception is that rapid testing sacrifices accuracy for speed. Rapid programs typically incorporate laboratory confirmation and medical review processes when needed, helping employers balance efficiency with defensibility.
• Myth #3: Some organizations still believe drug screening is only relevant for highly regulated industries. Today's workplace realities, including customer requirements, safety initiatives, and talent management goals, mean drug screening programs have become common across nearly every sector. For example, if there’s a change in someone’s license, that might trigger a closer look at their background. If someone moves or changes their name, the system adjusts with them.

Staying Ahead in a Changing Drug Screening Landscape

As regulations evolve and workplace risks become more complex, employers need a drug screening program that supports workplace safety, enables faster hiring, and helps navigate changing compliance requirements. Organizations that stay informed about emerging trends and testing options will be best positioned to build stronger, safer workforces.

Disclaimer: This content is provided for informational and educational purposes only and is not intended to constitute legal advice. It reflects general industry insights and best practices to support discussion and awareness. Organizations should consult with their legal, compliance, or other professional advisors before making changes to their background screening programs to ensure compliance with applicable laws and regulations.